» Authors » Aaron Schultz

Aaron Schultz

Explore the profile of Aaron Schultz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 1489
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Norton D, Parra M, Sperling R, Baena A, Guzman-Velez E, Jin D, et al.
Alzheimers Res Ther . 2020 Aug; 12(1):99. PMID: 32825838
Background: Over the past decade, visual short-term memory (VSTM) binding tests have been shown to be one of the most sensitive behavioral indicators of Alzheimer's disease (AD), especially when they...
12.
Dujon A, Gatenby R, Bramwell G, MacDonald N, Dohrmann E, Raven N, et al.
iScience . 2020 Jun; 23(7):101269. PMID: 32592998
Inter-individual transmission of cancer cells represents an intriguing and unexplored host-pathogen system, with significant ecological and evolutionary ramifications. The pathogen consists of clonal malignant cell lines that spread horizontally as...
13.
Rabin J, Shirzadi Z, Swardfager W, MacIntosh B, Schultz A, Yang H, et al.
Neurobiol Aging . 2020 Apr; 93:124-130. PMID: 32249013
In the present study, we tested the hypothesis that higher amyloid-beta (Aβ) burden at baseline is associated with greater longitudinal decline in body mass index (BMI) in clinically normal adults....
14.
Gatchel J, Lopera F, Norton D, Baena A, Guzman-Velez E, Sanchez J, et al.
J Neurol Neurosurg Psychiatry . 2019 Dec; 91(3):330-332. PMID: 31874859
No abstract available.
15.
Priyam A, Das R, Schultz A, Singh P
Sci Rep . 2019 Oct; 9(1):15083. PMID: 31636304
The study describes a novel and environment friendly route of biosynthesis of nanohydroxyapatite (nHAP). Bacillus licheniformis mediated synthesis of nHAP has been carried out with different phosphate concentrations (2%, 5%,...
16.
Shirvan J, Clement N, Ye R, Katz S, Schultz A, Johnson K, et al.
Neurology . 2019 Jun; 93(5):e476-e484. PMID: 31243072
Objective: To develop imaging biomarkers of diseases in the Lewy body spectrum and to validate these markers against postmortem neuropathologic findings. Methods: Four cognitively normal participants with Parkinson disease (PD),...
17.
Putcha D, Brickhouse M, Touroutoglou A, Collins J, Quimby M, Wong B, et al.
Neuroimage Clin . 2019 Jun; 23:101889. PMID: 31200149
Heterogeneity within the Alzheimer's disease (AD) syndromic spectrum is typically classified in a domain-specific manner (e.g., language vs. visual cognitive function). The central aim of this study was to investigate...
18.
Chen Z, Mengel D, Keshavan A, Rissman R, Billinton A, Perkinton M, et al.
Alzheimers Dement . 2018 Nov; 15(3):487-496. PMID: 30419228
Introduction: The tau protein plays a central role in Alzheimer's disease (AD), and there is huge interest in measuring tau in blood and cerebrospinal fluid (CSF). Methods: We developed a...
19.
Quiroz Y, Sperling R, Norton D, Baena A, Arboleda-Velasquez J, Cosio D, et al.
JAMA Neurol . 2018 Feb; 75(5):548-556. PMID: 29435558
Importance: It is critically important to improve our ability to diagnose and track Alzheimer disease (AD) as early as possible. Individuals with autosomal dominant forms of AD can provide clues...
20.
Makaretz S, Quimby M, Collins J, Makris N, McGinnis S, Schultz A, et al.
J Neurol Neurosurg Psychiatry . 2017 Oct; 89(10):1024-1031. PMID: 28986472
Objective: The semantic variant of primary progressive aphasia (svPPA) is typically associated with frontotemporal lobar degeneration (FTLD) with longTAR DNA-binding protein (TDP)-43-positive neuropil threads and dystrophic neurites (type C), and...